Genfit S.A. (GNFT) Stock Analysis

Genfit S.A. (GNFT) is a publicly traded company in the HEALTHCARE sector. It trades at $4.85. This page summarizes the public market data, fundamentals, and frequently asked questions for GNFT, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $4.85

Market Sentiment

Genfit S.A. currently has a Bullish sentiment score of 0.44.

About Genfit S.A.

Genfit S.A. is a biopharmaceutical company located in Loos, France, dedicated to the discovery and development of innovative therapeutics and diagnostic solutions for metabolic and liver-related diseases. With a strong emphasis on combating non-alcoholic steatohepatitis (NASH) and other liver disorders, Genfit utilizes proprietary technology platforms to advance its promising pipeline of drug candidates. The company is well-positioned in the biopharmaceutical sector, actively seeking strategi...

GNG Research Analysis

GNG Research scores Genfit S.A. (GNFT) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for GNFT.

Frequently Asked Questions

Does GNFT pay dividends?

Genfit S.A. (GNFT) does not currently pay a regular dividend.